Metraipolis › archive › dc_e209e25ae600
Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review — Europe PMC PMID:40963624
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40963624
- DOI
- 10.3389/fimmu.2025.1565803
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:22:37.374Z
- SHA-256 of the archived text
eea6ed61da00ea233f18a7b0d01237f2c64ad86ac16d21c2ca007e3bda754945- Stable URL of this page
https://metraipolis.com/documento/dc_e209e25ae600
How to cite
Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review — Europe PMC PMID:40963624 — Europe PMC (en), https://europepmc.org/article/MED/40963624 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e209e25ae600 (Metraipolis archive dc_e209e25ae600, sha256 eea6ed61da00ea233f18a7b0d01237f2c64ad86ac16d21c2ca007e3bda754945)
BibTeX
@misc{dce209e25ae600,
title = {Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review — Europe PMC PMID:40963624},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40963624},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e209e25ae600; sha256 eea6ed61da00ea233f18a7b0d01237f2c64ad86ac16d21c2ca007e3bda754945},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963624. Agents can read the archived copy with the MCP tool read_document.